Valvulopathies
JESFC 2025

Mieux prendre en charge les valvulopathies mitrales et tricuspides

Publié le mercredi 15 janvier 2025

Modérateur(s) :

Christelle Diakov , Nadjib Hammoudi

Orateur(s) :

Houda Ben Arbia , Caroline Chong-Nguyen , Pierre Vanhaecke , Nicolas Groshenry , Pierre Yves Turgeon , Corentin Bourg , Nora Henine , Alexandre Altes

Dans la session

Caroline Chong-Nguyen Impact of elevated transmitral mean gradient on cardiovascular mortality after transcatheter mitral valve implantation
Pierre Vanhaecke Natural history of isolated functional tricuspid regurgitation
Nicolas Groshenry Long-term Outcomes and Durability of Transcatheter Mitral Valve Replacement
Pierre Yves Turgeon Left ventricular myocardial work in degenerative mitral regurgitation and its impact on outcome
Corentin Bourg Too little, too late: atrial secondary tricuspid regurgitation (A-STR) carries a better prognosis in early-stage heart failure, but not in late-stage
Nora Henine Outcome of patients with severe secondary tricuspid regurgitation treated first with diuretics
Alexandre Altes Prognostic impact of cardiac magnetic resonance imaging characteristics in patients with primary mitral regurgitation
Houda Ben Arbia Prognostic Value of Mitral Annular Calcification in Patients with Severe Aortic Stenosis

Partager l'article :